Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Leukemia Research
|
March 10, 2005
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
Aisha Masood, Sabah Sallah
Current Drug Delivery
|
October 26, 2011
Novel approaches to modulate apoptosis resistance: basic and clinical implications in the treatment of chronic lymphocytic leukemia (CLL)
Aisha Masood, Mohammad A Shahshahan, Ali R Jazirehi
Current Opinion in Oncology
|
September 5, 2009
Targeting the Bcl-2
Mehul P Patel, Aisha Masood, Priya S Patel, et al.
Oncotargets and Therapy
|
December 14, 2011
Targeted treatment for chronic lymphocytic leukemia
Aisha Masood, Taimur Sher, Aneel Paulus, et al.
Journal of Comparative Effectiveness Research
|
June 22, 2023
Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma
Yanni Hao, Wei-Chun Hsu, Craig S Parzynski, et al.
Medical Oncology (Northwood, London, England)
|
January 8, 2013
Retrospective analysis of prognosticators in patients with relapsed Hodgkin's Lymphoma treated with autologous transplant: results of a single center
Aisha Masood, Amir Steinberg, Erin Moshier, et al.
The Journal of Supportive Oncology
|
January 7, 2012
Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients
Abhisek Swaika, Aneel Paulus, Kena C Miller, et al.
Transplantation and Cellular Therapy
|
October 1, 2022
Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA Study
Nathan Hale Fowler, Michael Dickinson, Monalisa Ghosh, et al.
British Journal of Haematology
|
December 17, 2011
Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner
Aisha Masood, Kasyapa Chitta, Aneel Paulus, et al.
Future Oncology (London, England)
|
June 18, 2024
End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
Evgeny Degtyarev, Natacha Bolaños, Joshua D Brody, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Leukemia Research
|
March 10, 2005
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
Aisha Masood, Sabah Sallah
Current Drug Delivery
|
October 26, 2011
Novel approaches to modulate apoptosis resistance: basic and clinical implications in the treatment of chronic lymphocytic leukemia (CLL)
Aisha Masood, Mohammad A Shahshahan, Ali R Jazirehi
Current Opinion in Oncology
|
September 5, 2009
Targeting the Bcl-2
Mehul P Patel, Aisha Masood, Priya S Patel, et al.
Oncotargets and Therapy
|
December 14, 2011
Targeted treatment for chronic lymphocytic leukemia
Aisha Masood, Taimur Sher, Aneel Paulus, et al.
Journal of Comparative Effectiveness Research
|
June 22, 2023
Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma
Yanni Hao, Wei-Chun Hsu, Craig S Parzynski, et al.
Medical Oncology (Northwood, London, England)
|
January 8, 2013
Retrospective analysis of prognosticators in patients with relapsed Hodgkin's Lymphoma treated with autologous transplant: results of a single center
Aisha Masood, Amir Steinberg, Erin Moshier, et al.
The Journal of Supportive Oncology
|
January 7, 2012
Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients
Abhisek Swaika, Aneel Paulus, Kena C Miller, et al.
Transplantation and Cellular Therapy
|
October 1, 2022
Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA Study
Nathan Hale Fowler, Michael Dickinson, Monalisa Ghosh, et al.
British Journal of Haematology
|
December 17, 2011
Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner
Aisha Masood, Kasyapa Chitta, Aneel Paulus, et al.
Future Oncology (London, England)
|
June 18, 2024
End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
Evgeny Degtyarev, Natacha Bolaños, Joshua D Brody, et al.
Page
of 3